Dabur India Limited is a 128-year-old Ayurvedic and FMCG company with a portfolio of over 250 herbal products. It has undergone strategic changes over four phases: initially focusing on Ayurvedic drugs, then expanding product lines and markets, restructuring under professional management to compete globally, and most recently rebranding and focusing on key brands and markets. Dabur now has annual revenues of over $600 million from consumer care, health, and international divisions, with a goal of doubling sales by 2010 through these divisions as well as foods.